-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Suspends Neutral Rating on Atrium Therapeutics

Benzinga·05/01/2026 11:11:01
Listen to the news
HC Wainwright & Co. suspends Neutral rating on Atrium Therapeutics (NASDAQ:RNA).